
Market Update by Liontrust – Q3 2024
Q3 2024 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
Q3 2024 review of the High Yield Market & the Liontrust High Yield Bond Fund, together with the outlook for the High Yield Market in general.
U.S. stocks are rebounding with strong Q3 earnings, leading to a preference for broad U.S. equities driven by resilient earnings and potential Fed rate cuts, while Japanese stocks remain appealing amid solid earnings, and weak growth keeps European stocks underweight except for select sectors like financials.
This week, market attention will focus on US quarterly earnings, the Fed’s Beige Book, and key international events like the IMF-World Bank meeting and BRICS summit, while central bank commentary and data releases, including US PMI, durable goods, and consumer sentiment, will shape economic outlooks amidst election-driven volatility; last week saw a mixed US economic picture, a strengthening dollar, lower oil prices due to demand concerns, and China’s economic stabilization efforts amid policy easing.
MeDirect Malta supported the Together for Financial Wellbeing Conference organised by JA Malta Foundation. The conference saw educators and financial services organisations come together to discuss how financial education in Malta can be improved.
Investing by yourself or with the help of an advisor depends on your financial goals, level of financial literacy, risk appetite and the time available to you. Explore the pros and cons of both options.
In this article, Stephen Yiu reflects on the Blue Whale Growth Strategy’s impressive performance over the past seven years, navigating a full market cycle and global uncertainties. Looking ahead, the strategy remains focused on identifying high-quality businesses poised for growth, with the aim of delivering consistent outperformance for investors in the future.
China’s stock surge highlights the benefit of targeting global opportunities with clear catalysts, while BlackRock maintains a U.S. equity overweight on expanding AI themes, favors Japanese stocks for their strong outlook, holds a less confident overweight in UK stocks, and upgrades UK gilts with expectations for deeper policy rate cuts.
In a US holiday-shortened week, markets will focus on retail sales, corporate earnings, and key data releases like UK and Eurozone CPI, while China’s GDP and fiscal measures draw attention; a mixed week saw a rise in the 10-year US Treasury yield, solid bank earnings boosting equities, and oil prices rising amid geopolitical concerns, with US inflation data remaining sticky despite some cooling signals.
MeDirect CEO Arnaud Denis talks about the bank’s digital transformation and its mission to democratise access to wealth management services.
MeDirect employees today visited YMCA to present a donation and deliver blankets. This is the latest initiative by MeDirect Malta staff to help and support those in the community who need it.
The sooner you start managing your money, your way, using the best-in-class tools, the sooner you’ll see results. Sign up and open your account for free, within minutes.
You are leaving medirect.com.mt
Please be aware that the external site policies, or those of another MeDirect website, may differ from this website’s terms and conditions and privacy policy. The next website will open in a new browser window or tab.
Note: MeDirect is not responsible for any content on third party sites, nor does a link suggest endorsement of those sites and/or their content.
We strive to ensure a streamlined account opening process, via a structured and clear set of requirements and personalised assistance during the initial communication stages. If you are interested in opening a corporate account with MeDirect, please complete an Account Opening Information Questionnaire and send it to corporate@medirect.com.mt.
For a comprehensive list of documentation required to open a corporate account please contact us by email at corporate@medirect.com.mt or by phone on (+356) 2557 4444.